Silexion Therapeutics LTD (SLXNW)
NASDAQ: SLXNW
· Real-Time Price · USD
0.07
0.00 (1.01%)
At close: Jun 09, 2025, 9:30 AM
Silexion Therapeutics LTD Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | 0.07 | -0.01 | -0.00 | -0.01 | -0.01 | -0.01 | -0.03 | 0.17 | 0.16 | 0.14 | 0.24 | 1.64 | -0.29 | -0.29 | -0.31 | -0.37 | -0.72 |
PEG Ratio | -0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 | -0.01 | 0.00 | 0.00 | -0.01 | -0.17 | -0.04 | -0.02 | -0.00 | 0.01 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.20 | -0.02 | -0.01 | -0.00 | -0.00 | -0.00 | 0.03 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/FCF Ratio | -0.21 | -0.02 | -0.01 | -0.07 | -0.04 | -0.06 | -0.14 | n/a | 0.39 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.35 |
P/OCF Ratio | -0.21 | -0.02 | -0.01 | -0.07 | -0.04 | -0.06 | -0.14 | n/a | 0.39 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.35 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.19 | -1.13 | -0.94 | -0.01 | -0.01 | -0.01 | 0.79 | 0.08 | 0.06 | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 3.22 | 0.64 | 0.85 | 0.98 | 1.72 | 2.27 | 2.25 | 12.26 | 0.06 | 0.08 | 0.32 | 0.33 | 0.62 | 1.17 | 6.10 | 7.07 | 13.00 |
Current Ratio | 3.22 | 0.64 | 0.85 | 0.98 | 1.72 | 2.27 | 2.25 | 12.26 | 0.06 | 0.08 | 0.32 | 0.33 | 0.62 | 1.17 | 6.10 | 7.07 | 13.00 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -692.5 | n/a | 40.19 | -16.24 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | 0.67 | 0.44 | 2.59 | 0.08 | 0.08 | 0.11 | -0.25 | 0.01 | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Assets | 0.21 | -0.61 | -3.84 | -0.58 | -0.38 | -0.33 | -0.14 | 0.01 | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Invested Capital | n/a | -3.79 | 30.10 | -5.06 | n/a | -0.29 | -0.13 | -0.01 | -0.02 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |